LncRNA DUXAP8 exhibited high expression levels in HCC and correlated with poor prognosis of patients, which promoted sorafenib resistance by inhibiting ferroptosis [128, 135]. The gene discussed is DUXAP8; the disease is hepatocellular carcinoma.